Kingswood Holdings

Director/PDMR Shareholding

RNS Number : 6003Q
Kingswood Holdings Limited
01 March 2021


1 March 2021



("Kingswood", the "Company" or the "Group")

Director/PDMR Shareholding




Kingswood Holdings Limited (AIM: KWG), the international fully integrated wealth and investment management group, announces that it has received notification of the following transaction in ordinary shares in the Company ("Ordinary Shares") by persons discharging managerial responsibilities.


The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.



 Details of PDMR / person closely associated



KPI (Nominees) Limited


 Reason for the notification


Position / Status

Company jointly owned by Gary Wilder, Group Chief Executive Officer, and Jonathan Massing, Non-Executive Deputy Chairman.


  Initial notification / Amendment

Initial notification


  Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor



Kingswood Holdings Limited





Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted


  Description of the financial instrument, type of instrument 

Identification code

Ordinary shares of 5 pence each in the Company




  Nature of the transaction

Purchase of ordinary shares of 5 pence in the Company


  Price (pence) and volume






  Aggregated information

-  Aggregated volume


-   Price (pence)



  Date of the transaction

26 February 2021


  Place of the transaction




For further details, please contact:


Kingswood Holdings Limited


+44 (0)20 7293 0730

David Lawrence / Patrick Goulding

Peel Hunt LLP (Nomad and Broker)

+44 (0)20 7418 8900

James Britton / Rishi Shah

Greentarget (for Kingswood media)

Jamie Brownlee / Alice Gasson / Ellie Basle 

+44 (0)20 7324 5498

[email protected]


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.